Literature DB >> 23677747

Stereotactic laser induced thermotherapy (LITT): a novel treatment for brain lesions regrowing after radiosurgery.

Juan Torres-Reveron1, Hilarie C Tomasiewicz, Anil Shetty, Nduka M Amankulor, Veronica L Chiang.   

Abstract

Since the inception of radiosurgery, the management of brain metastases has become a common problem for neurosurgeons. Although the use of stereotactic radiosurgery and/or whole brain radiation therapy serves to control the majority of disease burden, patients who survive longer than 6-8 months sometimes face the problem of symptomatic radiographically regrowing lesions with few treatment options. Here we investigate the feasibility of use of MRI-guided stereotactic laser induced thermotherapy (LITT) as a novel treatment option for these lesions. Six patients who had previously undergone gamma knife stereotactic radiosurgery for brain metastases were selected. All patients had an initial favorable response to radiosurgery but subsequently developed regrowth of at least one lesion associated with recurrent edema and progressive neurological symptoms requiring ongoing steroids for symptom control. All lesions were evaluated for craniotomy, but were deemed unresectable due to deep location or patient's comorbidities. Stereotactic biopsies were performed prior to the thermotherapy procedure in all cases. LITT was performed using the Visualase system and follow-up MRI imaging was used to determine treatment response. In all six patients biopsy results were negative for tumor and consistent with adverse radiation effects also known as radiation necrosis. Patients tolerated the procedure well and were discharged from the hospital within 48 h of the procedure. In 4/6 cases there was durable improvement of neurological symptoms until death. In all cases steroids were weaned off within 2 months. One patient died from systemic causes related to his cancer a month after the procedure. One patient had regrowth of the lesion 3 months after the procedure and required re-initiation of steroids and standard craniotomy for surgical resection. There were no complications directly related to the thermocoagulation procedure. Stereotactic laser induced thermotherapy is a feasible alternative for the treatment of symptomatic regrowing metastatic lesions after radiosurgery. The procedure carries minimal morbidity and, in this small series, shows some effectiveness in the symptomatic relief of edema and neurological symptoms paralleled by radiographic lesional control. Further studies are necessary to elucidate the safety of this technology.

Entities:  

Mesh:

Year:  2013        PMID: 23677747     DOI: 10.1007/s11060-013-1142-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

1.  Novel laser system and laser irradiation method reduced the risk of carbonization during laser interstitial thermotherapy: assessed by MR temperature measurement.

Authors:  H Atsumi; M Matsumae; M Kaneda; I Muro; Y Mamata; T Komiya; A Tsugu; R Tsugane
Journal:  Lasers Surg Med       Date:  2001       Impact factor: 4.025

2.  Interstitial thermotherapy of central brain tumors with the Nd:YAG laser under real-time monitoring by MRI.

Authors:  P W Ascher; E Justich; O Schröttner
Journal:  J Clin Laser Med Surg       Date:  1991-02

3.  Treatment planning for MRI-guided laser-induced interstitial thermotherapy of brain tumors--the role of blood perfusion.

Authors:  H J Schwarzmaier; I V Yaroslavsky; A N Yaroslavsky; V Fiedler; F Ulrich; T Kahn
Journal:  J Magn Reson Imaging       Date:  1998 Jan-Feb       Impact factor: 4.813

4.  Interstitial laserthermia in neurosurgery.

Authors:  T Sakai; I Fujishima; K Sugiyama; H Ryu; K Uemura
Journal:  J Clin Laser Med Surg       Date:  1992-02

Review 5.  ACR Appropriateness Criteria® follow-up and retreatment of brain metastases.

Authors:  Samir H Patel; Jared R Robbins; Elizabeth M Gore; Jeffrey D Bradley; Laurie E Gaspar; Isabelle Germano; Paiman Ghafoori; Mark A Henderson; Stephen T Lutz; Michael W McDermott; Roy A Patchell; H Ian Robins; Andrew D Vassil; Franz J Wippold; Gregory M Videtic
Journal:  Am J Clin Oncol       Date:  2012-06       Impact factor: 2.339

Review 6.  Phototherapy in tumors.

Authors:  S G Bown
Journal:  World J Surg       Date:  1983-11       Impact factor: 3.352

7.  Delayed radiation-induced vasculitic leukoencephalopathy.

Authors:  Philipp J Rauch; Henry S Park; Jonathan P S Knisely; Veronica L Chiang; Alexander O Vortmeyer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-10-22       Impact factor: 7.038

8.  Correlation of neuropathologic findings and phase-based MRI temperature maps in experimental laser-induced interstitial thermotherapy.

Authors:  P C Schulze; T Kahn; T Harth; H J Schwurzmaier; R Schober; C P Schulze
Journal:  J Magn Reson Imaging       Date:  1998 Jan-Feb       Impact factor: 4.813

9.  MR thermometry-based feedback control of laser interstitial thermal therapy at 980 nm.

Authors:  Roger J McNichols; Ashok Gowda; Marko Kangasniemi; James A Bankson; Roger E Price; John D Hazle
Journal:  Lasers Surg Med       Date:  2004       Impact factor: 4.025

10.  Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors.

Authors:  Alexandre Carpentier; Roger J McNichols; R Jason Stafford; Julian Itzcovitz; Jean-Pierre Guichard; Daniel Reizine; Suzette Delaloge; Eric Vicaut; Didier Payen; Ashok Gowda; Bernard George
Journal:  Neurosurgery       Date:  2008-07       Impact factor: 4.654

View more
  38 in total

Review 1.  Laser induced thermal therapy (LITT) for pediatric brain tumors: case-based review.

Authors:  Margaret Riordan; Zulma Tovar-Spinoza
Journal:  Transl Pediatr       Date:  2014-07

2.  Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Brain Metastases in the Motor Strip After Stereotactic Radiosurgery.

Authors:  Aditya Iyer; Casey H Halpern; Gerald A Grant; Sayantan Deb; Gordon H Li
Journal:  Cureus       Date:  2016-12-07

3.  Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases.

Authors:  Nanthiya Sujijantarat; Christopher S Hong; Kent A Owusu; Aladine A Elsamadicy; Joseph P Antonios; Andrew B Koo; Joachim M Baehring; Veronica L Chiang
Journal:  J Neurooncol       Date:  2020-06-29       Impact factor: 4.130

4.  Volumetric response of progressing post-SRS lesions treated with laser interstitial thermal therapy.

Authors:  Vivek B Beechar; Sujit S Prabhu; Dhiego Bastos; Jeffrey S Weinberg; R Jason Stafford; David Fuentes; Kenneth R Hess; Ganesh Rao
Journal:  J Neurooncol       Date:  2017-12-04       Impact factor: 4.130

5.  A multiport MR-compatible neuroendoscope: spanning the gap between rigid and flexible scopes.

Authors:  Sunil Manjila; Margherita Mencattelli; Benoit Rosa; Karl Price; Georgios Fagogenis; Pierre E Dupont
Journal:  Neurosurg Focus       Date:  2016-09       Impact factor: 4.047

6.  Laser Interstitial Thermal Therapy.

Authors:  Bhuvic Patel; Albert H Kim
Journal:  Mo Med       Date:  2020 Jan-Feb

7.  Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy.

Authors:  Jon T Willie; Nealen G Laxpati; Daniel L Drane; Ashok Gowda; Christina Appin; Chunhai Hao; Daniel J Brat; Sandra L Helmers; Amit Saindane; Sherif G Nour; Robert E Gross
Journal:  Neurosurgery       Date:  2014-06       Impact factor: 4.654

Review 8.  The Evaluation of Laser Application in Surgery: A Review Article.

Authors:  Ensieh Khalkhal; Majid Rezaei-Tavirani; Mohammad Reza Zali; Zahra Akbari
Journal:  J Lasers Med Sci       Date:  2019-12-01

Review 9.  The Treatment of Melanoma Brain Metastases.

Authors:  Nour Kibbi; Harriet Kluger
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

10.  Intraoperative real-time MRI-guided stereotactic biopsy followed by laser thermal ablation for progressive brain metastases after radiosurgery.

Authors:  Roy G Torcuator; M Maher Hulou; Vamsidhar Chavakula; Ferenc A Jolesz; Alexandra J Golby
Journal:  J Clin Neurosci       Date:  2015-11-16       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.